KOAN (Resonate Blends) Debt-to-Equity : -1.36 (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Debt-to-Equity?

Resonate Blends's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $3.57 Mil. Resonate Blends's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. Resonate Blends's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-2.64 Mil. Resonate Blends's debt to equity for the quarter that ended in Sep. 2024 was -1.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Resonate Blends's Debt-to-Equity or its related term are showing as below:

KOAN' s Debt-to-Equity Range Over the Past 10 Years
Min: -64.39 Med: -0.52 Max: 0.96
Current: -1.36

During the past 13 years, the highest Debt-to-Equity Ratio of Resonate Blends was 0.96. The lowest was -64.39. And the median was -0.52.

KOAN's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.27 vs KOAN: -1.36

Resonate Blends Debt-to-Equity Historical Data

The historical data trend for Resonate Blends's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonate Blends Debt-to-Equity Chart

Resonate Blends Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.27

-0.70

-0.46

-0.86

-1.15

Resonate Blends Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															-1.11	-1.15	-64.39	-1.28	-1.36

Competitive Comparison of Resonate Blends's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonate Blends's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Resonate Blends's Debt-to-Equity falls into.

Resonate Blends Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Resonate Blends's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.446	+	0)	/	-2.136
	=	-1.15

Resonate Blends's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.572	+	0)	/	-2.636
	=	-1.36

Resonate Blends (OTCPK:KOAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Resonate Blends Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonate Blends Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Marine Plaza, Suite 305A, North Bergen, NJ, USA, 04047

Website

https://www.resonateblends.com

Resonate Blends Inc engages in the discovery, development and marketing of products designed to better mankind. The company believes It is positioning its company as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. It is focusing its current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their adult stem cells from their bone marrow.

Executives

Richard Hoge	10 percent owner	C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin	officer: Chief Operating Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer	director, officer: Chief Executive Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen	10 percent owner, officer: COO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello	10 percent owner, officer: VP of Sales	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi	director, 10 percent owner, officer: CEO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii	director
Gregory Oliver Sargent	10 percent owner	1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester	officer: Vice President	3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane	other: Controller	50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley	director	945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley	director	2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr	director	2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee	officer: VP of Product Development
Jeffrey Longoria	officer: VP of Sales